Vadastuximab (Anti-Siglec-3 / CD33)

Vadastuximab (Anti-Siglec-3 / CD33) is a humanized monoclonal antibody targeting CD33. Vadastuximab can be used to synthesize an ADC compound, Vadastuximab talirine. MW : 150 KD.
Supplier Selleck Chemicals
Product # A2357
Sku # A2357-1mg*25
Pricing 1mg*25, $5070.00
Feedback